Healthed work with a team of general practitioners and medical professionals to ensure the highest quality education​
A/Prof Yet Hong Khor is an emerging research leader, who is in the top 0.1% of interstitial lung disease (ILD) and 0.45% of oxygen therapy researchers globally (Expertscape). In addition to dual clinical training in respiratory and sleep medicine, she completed a NHMRC-funded PhD in ILD and oxygen therapy at the University of Melbourne in 2019, and a post-doctoral fellowship at the University of British Columbia funded by an Australian Endeavour Leadership Award. Currently, she is an NHMRC Emerging Leadership fellow who leads investigator-initiated ILD research programs, as well as the Lead for Austin Health Oxygen Service and a specialist at the Austin and Alfred Health ILD Services.
Dr Yet Hong Khor is a graduate of the University of Tasmania, who attained her Fellowship to the Royal Australasian College of Physicians in 2014. After completing her NHRMC-funded PhD at the University of Melbourne in 2019, she undertook a fellowship at the Centre for Heart Lung Innovation (University of British Columbia, Canada), supported by an Australian Endeavour Scholarship. Currently, she is a post-doctoral fellow at the Institute for Breathing and Sleep, the lead for Austin Health Oxygen Service, and a physician at the Austin and Alfred Health Interstitial Lung Disease Services. Her main research interests include risk prediction and disease burden management in interstitial lung disease. She is the co-Chair of the Clinical Care and Resources Subcommittee and the Deputy Convener of the Orphan Lung Diseases, Lung Transplant, Interstitial lung Disease and Pulmonary Vascular Disease (OLIV) Special Interest Group for the Thoracic Society of Australia and New Zealand.
A/Prof Teh is a fertility specialist and gynecologist at City Fertility and Epworth Healthcare (Freemason and Eastern). She is also co-medical director of Public Fertility Services at the Royal Women’s Hospital. She holds the degrees of Bachelor of Medicine and Bachelor of Surgery from Monash University, Masters of Reproductive Medicine from University of New South Wales and Doctor of philosophy (PhD) from University of Melbourne.
A/Prof Teh has more than 15 years’ experience in the field of Obstetrics & Gynaecology. She completed her general specialist training in obstetrics and gynaecology at Monash Medical Centre, before joining Reproductive Services Unit at The Royal Women’s Hospital and subsequently City Fertility.
A/Prof Teh has a passion in research and teaching. She has been appointed honorary Associate Professor at the University of Melbourne, and is actively involved in supervision of both clinical and research students and specialist trainees.
Her main research interest is on endometrium, implantation failure and to improve obstetric outcomes following IVF treatments. She has received multiple scholarships, research grants and awards during her career.
Dr Ted Wu, Endocrinologist; Senior Specialist Endocrinologist, Director, Royal Prince Alfred Hospital Diabetes Centre; Director of Physician Training, Royal Prince Alfred Hospital, Sydney
Dr Ted Wu is a senior specialist endocrinologist, Director of the Royal Prince Alfred (RPA) Hospital Diabetes Centre and Director of Physician Training at Royal Prince Alfred Hospital in Sydney, Australia.
He has a long-term interest clinical diabetes, and teaching and research into diabetes complications and novel treatments.
In 1998 he joined the RPA Diabetes Centre, formulating and delivering novel educational programs in clinical diabetes.
He has published numerous articles, abstracts and book chapters and has been an invited speaker to many international symposia.
He was instrumental in establishing RPA Hospital’s Diabetes Centre as a National Association of Diabetes Centre’s ‘Centre of Excellence’ and Australia’s only International Diabetes Federation ‘Centre of Education’.
Prof Kovacic graduated from The University of Melbourne Medical School in 1994, and then undertook residency and cardiology specialty training in interventional cardiology at St Vincent’s Hospital in Sydney, becoming a Fellow of The Royal Australasian College of Physicians in 2003. Prof Kovacic then completed a PhD in cardiovascular medicine at the Victor Chang Cardiac Research Institute.
In 2007, he was elected as a Fellow of The American College of Cardiology and relocated to the USA, to the National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, Maryland. At the NIH, Professor Kovacic discovered critical new pathways that lead to blockage of the body’s blood vessels. He then moved to The Icahn School of Medicine at Mount Sinai in New York. In parallel with his vital ongoing research to define new ways to prevent and treat vascular disease, Prof Kovacic is a practicing clinical cardiologist at St Vincent’s Hospital, Sydney, specialising in vascular disease and blockages of the heart arteries.
Prof Kovacic has authored numerous scientific and clinical papers on heart and vascular disease and serves on a number of NIH committees. He has a particular interest in unraveling the pathobiology of the vascular diseases, fibromuscular dysplasia and spontaneous coronary artery dissection.